MaramaLabs

Wellington, New Zealand Founded: 2017 • Age: 9 yrs
Scatter-free UVVis spectroscopy is developed for biomolecule quantification in nanoparticles.
Annual revenue - Latest available
Total funding $4.8M 4 rounds
Employees 2 Tracked headcount
Investors 10 Known backers
Products 2 Services tracked
Competitors 10 Brand Intelligence

About MaramaLabs

MaramaLabs is a company based in Wellington (New Zealand) founded in 2017 by Matthias Meyer and Brendan Darby. MaramaLabs has raised $4.81 million across 4 funding rounds from investors including Enterprise Ireland, The Yield Lab and DeepIE Ventures. The company has 2 employees as of March 31, 2020. MaramaLabs offers products and services including CloudSpec and Scatter-Free Absorption Technology. MaramaLabs operates in a competitive market with competitors including Impedimed, VUV Analytics, Rigaku, Speclipse and Linear Diagnostics, among others.

  • Headquarter Wellington, New Zealand
  • Employees 2 as on 31 Mar, 2020
  • Founders Matthias Meyer, Brendan Darby
  • Sectors
    Healthcare
    Technology
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Marama Labs Limited
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Technology → Quantum & Emerging Technologies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $4.81 M (USD)

    in 4 rounds

  • Latest Funding Round
    $2.09 M (USD), Seed

    Dec 19, 2024

  • Investors
  • Employee Count
    2

    as on Mar 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of MaramaLabs

MaramaLabs offers a comprehensive portfolio of products and services, including CloudSpec and Scatter-Free Absorption Technology.

Product name locked
Category locked
Primary

Device for scatter-free UV/Vis quantification of nanoparticle payloads.

Product name locked
Category locked
Locked

Technology to eliminate scatter in UV analysis for accurate biomolecule quantification.

People of MaramaLabs

Headcount 1-10
Employee Profiles 7
Board Members and Advisors 2
Employee Profiles
People
Jack Bannister-Sutton
Senior Hardware Engineer
People
Matthias Meyer
Chief Technical Officer & Co-Founder
People
Luke Hudson
Software Lead
People
Brendan Darby
CEO

Unlock access to complete

Board Members and Advisors
people
MJ Alvarez
Director
people
Mark Bregman
Director

Unlock access to complete

Funding Insights of MaramaLabs

MaramaLabs has successfully raised a total of $4.81M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.09 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in MaramaLabs

MaramaLabs has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, The Yield Lab and DeepIE Ventures.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital firm & accelerator focused on early-stage companies
Locked Locked Locked
Early-stage venture capital investments are made globally by DeepIE Ventures.
Locked Locked Locked
Venture capital investments are targeted through managed funds of funds.
Locked Locked Locked
Premium access

Investor details for MaramaLabs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MaramaLabs

Investments
Premium access

Investment portfolio details for MaramaLabs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - MaramaLabs

Premium access

Detailed financials for MaramaLabs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Maramalabs Comparisons

MaramaLabs Primary company
Description
Scatter-free UV/Vis spectroscopy is developed for biomolecul...
Location
Wellington, New Zealand
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
2
As of 2020
Premium access

Peer comparison for MaramaLabs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of MaramaLabs

MaramaLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Impedimed, VUV Analytics, Rigaku, Speclipse and Linear Diagnostics, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Technologies for non-invasive fluid status assessment and monitoring are developed.
Locked Locked Locked
Vacuum ultraviolet absorption spectroscopic instruments are supplied for gas analysis.
Locked Locked Locked
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
Locked Locked Locked
Molecular spectroscopy systems for early skin cancer detection are provided.
Locked Locked Locked
Molecular diagnostic tests for sexually transmitted infections are developed.
Locked Locked Locked
Optical systems are developed for identifying solid and liquid chemicals.
Premium access

Detailed competitors of MaramaLabs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Maramalabs

Premium access

Complete news archive for MaramaLabs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MaramaLabs

MaramaLabs was founded in 2017 and raised its 1st funding round 4 years after it was founded.

MaramaLabs is headquartered in Wellington, New Zealand.

Brendan Darby is the current CEO of MaramaLabs. They have also founded this company.

MaramaLabs is a funded company, having raised a total of $4.81M across 4 funding rounds to date.

As of Mar 31, 2020, the latest employee count at MaramaLabs is 2.

MaramaLabs was founded in 2017 in Wellington, New Zealand, as a developer of scatter-free UVVis spectroscopy technology. This innovation is applied in the biotechnology sector to quantify biomolecules, such as RNA, within nanoparticles including therapeutic particles, liposomes, lipid nanoparticles, and metal nanoparticles. Accurate absorption spectra are measured without light scattering interference, eliminating the need for lysis or fluorescent assays. The technology is also utilized for monitoring bacterial and cellular growth.

MaramaLabs's top competitors include Impedimed, VUV Analytics and Linear Diagnostics.

MaramaLabs offers CloudSpec and Scatter-Free Absorption Technology.

MaramaLabs has 10 investors. Key investors include Enterprise Ireland, The Yield Lab, DeepIE Ventures, New Zealand Growth Capital Partners, and Radar Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available